California State Teachers Retirement System (CalSTRS)’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,522
Closed -$7.24K 2999
2025
Q1
$7.24K Hold
4,522
﹤0.01% 2854
2024
Q4
$16.3K Buy
4,522
+274
+6% +$1.36K ﹤0.01% 2681
2024
Q3
$24.2K Hold
4,248
﹤0.01% 2541
2024
Q2
$19.6K Buy
+4,248
New +$25.3K ﹤0.01% 2601
2023
Q2
Sell
-45,664
Closed -$143K 3130
2023
Q1
$143K Sell
45,664
-861
-2% -$5.07K ﹤0.01% 2636
2022
Q4
$274K Buy
46,525
+530
+1% +$4.39K ﹤0.01% 2552
2022
Q3
$403K Sell
45,995
-723
-2% -$7.51K ﹤0.01% 2423
2022
Q2
$352K Buy
46,718
+19,833
+74% +$175K ﹤0.01% 2524
2022
Q1
$652K Sell
26,885
-4,306
-14% -$105K ﹤0.01% 2274
2021
Q4
$1M Buy
31,191
+1,459
+5% +$57.7K ﹤0.01% 2159
2021
Q3
$1.33M Sell
29,732
-17,757
-37% -$760K ﹤0.01% 1966
2021
Q2
$1.8M Buy
47,489
+31,349
+194% +$1.12M ﹤0.01% 1836
2021
Q1
$597K Hold
16,140
﹤0.01% 2438
2020
Q4
$535K Buy
+16,140
New +$468K ﹤0.01% 2394

Other funds holding CCCC

California State Teachers Retirement System (CalSTRS)'s CCCC Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of C4 Therapeutics (CCCC) in Q2 2025, closing a stake of 4,522 shares — an estimated $7.24K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CCCC in Q4 2020 and held it in 14 quarters. The position peaked at $1.8M in Q2 2021. 102 funds tracked by Wall St. Rank hold CCCC as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining C4 Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 4,522 C4 Therapeutics shares in Q2 2025, an estimated $7.24K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in C4 Therapeutics in Q4 2020 and held it in 14 quarters.
  • California State Teachers Retirement System (CalSTRS)'s C4 Therapeutics position peaked at $1.8M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.